z-logo
Premium
Unexpectedly high incidence of indigenous acute hepatitis E within South Hampshire: Time for routine testing?
Author(s) -
De Silva Aminda N.,
Muddu Ajay K.,
Iredale John P.,
Sheron Nick,
Khakoo Salim I.,
Pelosi Emanuela
Publication year - 2008
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.21062
Subject(s) - virology , indigenous , incidence (geometry) , medicine , geography , biology , physics , optics , ecology
Hepatitis E indigenous to developed countries (hepatitis E IDC ) is a form of hepatitis E in persons with no travel history to highly endemic areas. It has been recognized recently as an emerging clinical entity in a significant number of economically developed countries including UK. However, it is still perceived as a rare disease and routine laboratory testing for hepatitis E is not performed. A series of 13 cases of hepatitis E IDC , diagnosed in a 13‐month period from June 2005 within a single center in South Hampshire, UK, is presented. These patients were identified after implementing a novel‐screening algorithm that introduced routine hepatitis E serological investigations. Patients were middle aged or elderly and males were affected more commonly. Four patients (31%) required hospital admission. All reverse transcriptase‐polymerase chain reaction (RT‐PCR) confirmed cases carried hepatitis E virus (HEV) genotype‐3, which bore close sequence homology to HEV circulating in UK pigs. None of these patients recalled eating undercooked pork products or close contact with pigs during the 2 months preceding the onset of acute hepatitis. In comparison, during the same period, only two cases of hepatitis A and five cases of acute hepatitis B were diagnosed. These data illustrate the importance of introducing routine hepatitis E testing in all patients with unexplained acute liver disease and absence of relevant travel history. Routine testing can clarify hepatitis E epidemiology whilst improving the clinical management of patients with acute liver disease. J. Med. Virol. 80:283–288, 2008. © 2007 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom